(19)
(11) EP 1 576 010 A2

(12)

(88) Date of publication A3:
14.07.2005

(43) Date of publication:
21.09.2005 Bulletin 2005/38

(21) Application number: 03749129.7

(22) Date of filing: 25.08.2003
(51) International Patent Classification (IPC)7: C07K 16/00
(86) International application number:
PCT/US2003/026612
(87) International publication number:
WO 2004/017923 (04.03.2004 Gazette 2004/10)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 23.08.2002 US 405577 P
22.08.2003 US 646934

(71) Applicant: CHIRON CORPORATION
California 94608-2916 (US)

(72) Inventors:
  • WONG, Justin
    Oakland, CA 94611 (US)
  • WINTER, Jill
    Richmond, CA 94805 (US)
  • LALEHZADEH, Guita
    Oakland, CA 94606 (US)
  • WARNE, Robert
    San Leandro, CA 94577 (US)

(74) Representative: UEXKÜLL & STOLBERG 
Patentanwälte Beselerstrasse 4
22607 Hamburg
22607 Hamburg (DE)

   


(54) COMPOSITIONS AND METHODS OF THERAPY FOR CANCERS CHARACTERIZED BY EXPRESSION OF THE TUMOR-ASSOCIATED ANTIGEN MN/CA IX